Goldman Sachs Upgrades Carter's (CRI) to Neutral
Goldman Sachs analyst Jon Keypour upgraded Carter's (NYSE: CRI) from Sell to Neutral with a price target of $38.00.The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
